Press Releases

The global cellular health screening market size was valued at USD 2.8 billion in 2023. It is likely to grow up to USD 9.4 billion by 2030 at a CAGR of 9.3% during the forecast period ranging between 2025 and 2030.

Major technological developments and use of sophisticated diagnostic tools increase accessibility. Integration of data analytics and more advanced technologies such as artificial intelligence increases the accuracy of screening process. This promotes adoption of the process and reliability of diagnostic results which further fuels the growth of the market. The growth of the global cellular health screening market is the result of growing preference among people for preventive healthcare. However, expensive technologies that increase screening costs are hindering the market growth.

Browse market data Tables and Figures spread through 150 Pages and in-depth TOC on Global Cellular Health Screening Market Test Type (Telomere Test, Oxidative Stress Test, and Inflammation Marker Test, Single Biomarker Tests, and Panel Tests), By Sample Type (Blood, Urine, Saliva, Tissue, Hair, and Buccal Swabs), By End User (Home Care Settings,Hospitals and Clinics, Research Institutes, Diagnostic Laboratories, and further categories), By Application (Routine Health Check-ups, Disease Risk Assessment, Preventive Healthcare, Research and Development sections) and By Geography (North America, Europe, Asia Pacific and Rest of the World) - Forecast from 2025 to 2030.

Global Cellular Health Screening Market Segmentation and Key Players

By test type, telomere dominated the global cellular health screening market.  

The telomere tests dominate the market due to wider application including cardiovascular conditions and cancer and developments in the techniques. 

"North America dominates the global cellular health screening market." 

North America leads the global cellular health screening market due to the developed healthcare infrastructure and rising expenditure. It is also the result of rising awareness among people of preventive healthcare.

Some of the key players in this market are Genova Diagnostics, Life Length, Telomere Diagnostics, Cell Science Systems, Spectracell Laboratories

Recent Developments by the Key Players

Genova Diagnostics which is a global leader in clinical laboratory services, has partnered with Neurocode, a leading innovator in neurological diagnostics and research to launch its groundbreaking Alzheimer’s Assessment, a non-invasive blood test utilizing the p-Tau217 biomarker for early detection of Alzheimer’s disease. 

The Global Cellular Health Screening Market report offers a comprehensive market segmentation analysis along with estimation for the forecast period 2025–2030.

Global Cellular Health Screening Market coverage (By Value)

• Test Type Insight and Forecast 2025 - 2030
  • Telomere Test
  • Oxidative Stress Test
  • and Inflammation Marker Test
  • Single Biomarker Tests
  • Panel Tests
• Sample Type Insight and Forecast 2025 - 2030
  • Blood
  • Urine
  • Saliva
  • Tissue
  • Hair
  • Buccal Swabs
• End user Insight and Forecast 2025 - 2030
  • Home Care Settings
  • Hospitals and Clinics
  • Research Institutes
  • Diagnostic Laboratories
  • Others
• Application Insight and Forecast 2025 - 2030
  • Routine Health Check-ups
  • Disease Risk Assessment
  • Preventive Healthcare
  • Research and Development sections

Geographical Segmentation

Global Cellular Health Screening Market by Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia-Pacific (APAC)
  • China
  • Japan
  • India
  • South Korea
  • Vietnam
  • Thailand
  • Malaysia
  • Rest of Asia-Pacific
• Rest of the World (RoW)
  • Brazil
  • Saudi Arabia
  • South Africa
  • U.A.E.
  • Other Countries